Study of 203Pb-RMX-VH-PIB Dosimetry and Biodistribution in Patients With Glioblastoma Multiform (GBM) and Pancreatic Ductal Adenocarcinoma (PDAC)

Clinical trial NCT07733674 · RECRUITING

Trial details

NCT number: NCT07733674
Sponsor: Radiomedix, Inc.
Status: RECRUITING
Phase: Phase 1
Study type: INTERVENTIONAL

Glioblastoma Multiforme (GBM)Pancreatic Ductal Adenocarcinoma (PDAC)

Start date: 2026-08-15
Primary completion: 2026-12-31
Enrollment: 20

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.